Ghebremariam YT - Search Results

1

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.

Ghebremariam YT, Cooke JP, Gerhart W, Griego C, Brower JB, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD. Ghebremariam YT, et al. J Transl Med. 2015 Aug 1;13:249. doi: 10.1186/s12967-015-0614-x. J Transl Med. 2015. PMID: 26231702 Free PMC article.

2

Endothelial nicotinic acetylcholine receptors and angiogenesis.

Cooke JP, Ghebremariam YT. Cooke JP, et al. Among authors: ghebremariam yt. Trends Cardiovasc Med. 2008 Oct;18(7):247-53. doi: 10.1016/j.tcm.2008.11.007. Trends Cardiovasc Med. 2008. PMID: 19232953 Free PMC article. Review.

3

Dietary nitrate, nitric oxide, and restenosis.

Cooke JP, Ghebremariam YT. Cooke JP, et al. Among authors: ghebremariam yt. J Clin Invest. 2011 Apr;121(4):1258-60. doi: 10.1172/JCI57193. Epub 2011 Mar 23. J Clin Invest. 2011. PMID: 21436578 Free PMC article.

4

Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP. Ghebremariam YT, et al. Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3. Circulation. 2013. PMID: 23825361 Free PMC article.

5

A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

Ghebremariam YT, Erlanson DA, Cooke JP. Ghebremariam YT, et al. J Pharmacol Exp Ther. 2014 Jan;348(1):69-76. doi: 10.1124/jpet.113.206847. Epub 2013 Oct 17. J Pharmacol Exp Ther. 2014. PMID: 24135074 Free PMC article.

6

Proton pump inhibitors and vascular function: A prospective cross-over pilot study.

Ghebremariam YT, Cooke JP, Khan F, Thakker RN, Chang P, Shah NH, Nead KT, Leeper NJ. Ghebremariam YT, et al. Vasc Med. 2015 Aug;20(4):309-16. doi: 10.1177/1358863X14568444. Epub 2015 Apr 2. Vasc Med. 2015. PMID: 25835348 Free PMC article. Clinical Trial.

7

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.

Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, Nead KT, Cooke JP, Leeper NJ. Shah NH, et al. Among authors: ghebremariam yt. PLoS One. 2015 Jun 10;10(6):e0124653. doi: 10.1371/journal.pone.0124653. eCollection 2015. PLoS One. 2015. PMID: 26061035 Free PMC article.

8

Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening.

Ghebremariam YT, Erlanson DA, Yamada K, Cooke JP. Ghebremariam YT, et al. J Biomol Screen. 2012 Jun;17(5):651-61. doi: 10.1177/1087057112441521. Epub 2012 Mar 29. J Biomol Screen. 2012. PMID: 22460174 Free PMC article.

9

Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine".

Ghebremariam YT, Lee JC, LePendu P, Erlanson DA, Slaviero A, Shah NH, Leiper JM, Cooke JP. Ghebremariam YT, et al. Circulation. 2014 Apr 1;129(13):e428. doi: 10.1161/CIRCULATIONAHA.114.009343. Circulation. 2014. PMID: 24687654 Free PMC article. No abstract available.

10

Lansoprazole worsens asthma control in poor metabolizers: is nitric oxide involved?

Sukhovershin RA, Ghebremariam YT, Cooke JP. Sukhovershin RA, et al. Among authors: ghebremariam yt. Ann Am Thorac Soc. 2015 Jul;12(7):1109-10. doi: 10.1513/AnnalsATS.201504-238LE. Ann Am Thorac Soc. 2015. PMID: 26203616 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page